Vorsitz: S. Fichtlscherer (Frankfurt am Main), T. Thum (Hannover)
| (V1555) | Microparticle-based delivery of microRNA-494 from endothelial cells to cardiomyocytes mediates anti-apoptotic effects |
| A. C. Maron, M. Christa, E. Hergenreider, R. A. Boon, A. M. Zeiher, S. Dimmeler (Frankfurt am Main) | |
| (V1556) | Paracrine microRNA-crosstalk between cardiac fibroblasts and cardiomyocytes |
| C. Bang, S. Batkai, A. Zeug, S. Dangwal, A. Schmiedl, M. Mayr, T. Thum (Hannover; London, UK) | |
| (V1557) | Upregulation of miRNA-208b during pathogenesis of dilated cardiomyopathy |
| M. Gramlich, Q. Zhou, S. Schötterl, E. C. Brunner, R. Kandolf, M. Gawaz (Tübingen) | |
| (V1558) | miR-378 controls cardiac hypertrophy by combined repression of MAP kinase pathway factors |
| J. Ganesan, D. P. Ramanujam, Y. Sassi, A. Ahles, C. Jentzsch, S. Werfel, S. Leierseder, X. Loyer, M. Giacca, L. Zentilin, B. Laggarbauer, S. Engelhardt (München; Trieste, IT) | |
| (V1559) | Inhibition of microRNA-146a Enhances Angiogenesis and Preserves Cardiac Function Following Myocardial Infarction |
| K. Knoepp, R. Widmer-Teske, W. Bielenberg, J. M. Daniel, C. Troidl, H. M. Nef, C. W. Hamm, D. G. Sedding (Gießen, Bad Nauheim) | |
| (V1560) | Cardioprotective Potential of LNA-mediated miR-92a Suppression |
| S. Zühlke, R. Hinkel, D. Penzkofer, W. Husada, A. Fischer, E. van Rooij, A. M. Zeiher, S. Massberg, S. Dimmeler, C. Kupatt (München, Frankfurt am Main; Boulder, US) |